Genetic Determinants of Long-Term Changes in Blood Lipid Concentrations: 10-Year Follow-Up of the GLACIER Study

PLoS Genetics

Volumn 10, Issue 6, 2014, Pages

  Varga, Tibor V ^a   Sonestedt, Emily ^b   Shungin, Dmitry ^a,c   Koivula, Robert W ^a   Hallmans, Göran ^c   Escher, Stefan A ^a   Barroso, Inês ^d,e,f   Nilsson, Peter ^a   Melander, Olle ^b   Orho Melander, Marju ^b   Renström, Frida ^a,c   Franks, Paul W ^a,c,g  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; PROTEIN KINASE; TRIACYLGLYCEROL; TRIBBLES PSEUDOKINASE 1; UNCLASSIFIED DRUG; APOA1 PROTEIN, HUMAN; CHOLESTEROL; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TRIB1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL; ANTAGONISTS AND INHIBITORS; BLOOD; CROSS-SECTIONAL STUDY; GENETICS; LIFESTYLE; LONGITUDINAL STUDY; MIDDLE AGED; PROSPECTIVE STUDY; QUESTIONNAIRE;

AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; CHOLESTEROL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PROTEIN-SERINE-THREONINE KINASES; QUESTIONNAIRES; SWEDEN; TRIGLYCERIDES;

EID: 84903472554     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004388     Document Type: Article

References (48)

1. Visscher PM, Brown MA, McCarthy MI, Yang J, (2012) Five years of GWAS discovery. Am J Hum Genet 90: 7-24.
2. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
3. Global Lipids Genetics Consortdium (2013) Willer CJ, Schmidt EM, Sengupta S, Peloso GM, et al. (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45: 1274-1283.
4. Middelberg RP, Martin NG, Whitfield JB, (2006) Longitudinal genetic analysis of plasma lipids. Twin Res Hum Genet 9: 550-557.
5. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938-2939.
6. Jostins L, Barrett JC, (2011) Genetic risk prediction in complex disease. Hum Mol Genet 20: R182-188.
7. Lutsey PL, Rasmussen-Torvik LJ, Pankow JS, Alonso A, Smolenski DJ, et al. (2012) Relation of lipid gene scores to longitudinal trends in lipid levels and incidence of abnormal lipid levels among individuals of European ancestry: the Atherosclerosis Risk in Communities (ARIC) study. Circ Cardiovasc Genet 5: 73-80.
8. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, et al. (2012) Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380: 572-580.
9. Costanza MC, Beer-Borst S, James RW, Gaspoz JM, Morabia A, (2012) Consistency between cross-sectional and longitudinal SNP: blood lipid associations. Eur J Epidemiol 27: 131-138.
10. Lu Y, Feskens EJ, Boer JM, Imholz S, Verschuren WM, et al. (2010) Exploring genetic determinants of plasma total cholesterol levels and their predictive value in a longitudinal study. Atherosclerosis 213: 200-205.
11. Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, et al. (2009) Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41: 35-46.
12. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, et al. (2009) Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41: 47-55.
13. Kiss-Toth E, Bagstaff SM, Sung HY, Jozsa V, Dempsey C, et al. (2004) Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem 279: 42703-42708.
14. Burkhardt R, Toh SA, Lagor WR, Birkeland A, Levin M, et al. (2010) Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. J Clin Invest 120: 4410-4414.
15. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, et al. (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40: 161-169.
16. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, et al. (2008) Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40: 189-197.
17. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, et al. (2010) Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 30: 2264-2276.
18. Varbo A, Benn M, Tybjaerg-Hansen A, Grande P, Nordestgaard BG, (2011) TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population. Arterioscler Thromb Vasc Biol 31: 451-457.
19. Sung HY, Guan H, Czibula A, King AR, Eder K, et al. (2007) Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways. J Biol Chem 282: 18379-18387.
20. Drenos F, Talmud PJ, Casas JP, Smeeth L, Palmen J, et al. (2009) Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Hum Mol Genet 18: 2305-2316.
21. Smelt AH, de Beer F, (2004) Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects. Semin Vasc Med 4: 249-257.
22. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, et al. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41: 56-65.
23. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, et al. (2009) Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302: 37-48.
24. Golledge J, Biros E, Cooper M, Warrington N, Palmer LJ, et al. (2010) Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm. Atherosclerosis 209: 487-491.
25. Kristiansson K, Perola M, Tikkanen E, Kettunen J, Surakka I, et al. (2012) Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet 5: 242-249.
26. Xu L, Zhou J, Huang S, Huang Y, Le Y, et al. (2013) An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease. Exp Ther Med 5: 742-750.
27. Tragante V, Doevendans PA, Nathoe HM, van der Graaf Y, Spiering W, et al. (2013) The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk. Eur Heart J 34: 2896-2904.
28. Hallmans G, Agren A, Johansson G, Johansson A, Stegmayr B, et al. (2003) Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort- evaluation of risk factors and their interactions. Scand J Public Health Suppl 61: 18-24.
29. Norberg M, Wall S, Boman K, Weinehall L (2010) The Vasterbotten Intervention Programme: background, design and implications. Glob Health Action 3.
30. Hedblad B, Nilsson P, Janzon L, Berglund G, (2000) Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden. Diabet Med 17: 299-307.
31. Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, et al. (2001) The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 10: 489-499.
32. American Heart Association (AHA)- What Your Cholesterol Levels Mean. Available: http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/What-Your-Cholesterol-Levels-Mean_UCM_305562_Article.jsp. Accessed 05 May 2013.
33. Rosvall M, Ostergren PO, Hedblad B, Isacsson SO, Janzon L, et al. (2000) Occupational status, educational level, and the prevalence of carotid atherosclerosis in a general population sample of middle-aged Swedish men and women: results from the Malmo Diet and Cancer Study. Am J Epidemiol 152: 334-346.
34. Friedewald WT, Levy RI, Fredrickson DS, (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
35. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR, (2005) Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 24: 2911-2935.
36. Eliasson M, Janlert U, Jansson JH, Stegmayr B, (2006) Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med 260: 551-559.
37. Wu J, Province MA, Coon H, Hunt SC, Eckfeldt JH, et al. (2007) An investigation of the effects of lipid-lowering medications: genome-wide linkage analysis of lipids in the HyperGEN study. BMC Genet 8: 60.
38. Franks PW, Rolandsson O, Debenham SL, Fawcett KA, Payne F, et al. (2008) Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia 51: 458-463.
39. Renstrom F, Payne F, Nordstrom A, Brito EC, Rolandsson O, et al. (2009) Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden. Hum Mol Genet 18: 1489-1496.
40. Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, et al. (2012) The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 8: e1002793.
41. Cornelis MC, Qi L, Zhang C, Kraft P, Manson J, et al. (2009) Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann Intern Med 150: 541-550.
42. Fontaine-Bisson B, Renstrom F, Rolandsson O, Magic, Payne F, et al. (2010) Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population. Diabetologia 53: 2155-2162.
43. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
44. SAS Institute (2011) The SAS system for Windows, version 9.2. SAS Institute, Cary, NC, USA.
45. StataCorp (2011) Stata Statistical Software, version 12.1. College Station, TX: StataCorp LP, USA.
46. R Development Core Team (2008) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
47. Miller RG (1981) Simultaneous statistical inference. 2nd ed.: Springer Verlag. pp. 6-8.
48. Harris RJ, Deeks JJ, Altman DG, Bradburn MJ, Harbord RM, et al. (2008) metan: fixed- and random-effects meta-analysis. The Stata Journal 8: pp. 3-28.